NCT05579665View on ClinicalTrials.gov

Effectiveness of PRP, Conditioned Medium UC-MSCs Secretome and Hyaluronic Acid for the Treatment of Knee Osteoarthritis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 2, 2022

Primary Completion Date

March 31, 2023

Study Completion Date

May 31, 2023

Conditions
Knee Osteoarthritis
Interventions
BIOLOGICAL

Platelet-rich Plasma

Research participants own blood will be used to prepare the platelet rich plasma injectate.

BIOLOGICAL

Conditioned Medium From Umbilical Cord Mesenchymal Stem Cell Culture (MSCs) Secretome

Conditioned Medium UC-MSCs Secretome which will be injected into the affected knee using ultrasound guidance.

DRUG

Low Molecular Weight Hyaluronic Acid

low molecular weight hyaluronic acid which will be injected into the affected knee using ultrasound guidance.

Trial Locations (1)

30114

Mohammad Hoesin Central General HospitalPalembang, Palembang

All Listed Sponsors
collaborator

Dr. Mohammad Hoesin Central General Hospital

UNKNOWN

lead

Universitas Sriwijaya

OTHER